Drug approvals - Page 2 of 73 - Express Pharma

FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape

Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart

AstraZeneca gains CDSCO approval for treatment of muscle-invasive bladder cancer

Biocon Biologics gains UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars

EU approves Biocon Biologics’ Denosumab biosimilars

AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country

First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved

Lupin gains USFDA approval for Loteprednol Etabonate Ophthalmic Gel

Alembic Pharmaceuticals receives US FDA approval for Doxorubicin Hydrochloride Liposome injection

Lupin launches Prucalopride Tablets in the US market post FDA approval